The American Journal of Managed Care

Dr Parth Rali Explains Challenges of Managing Intermediate-Risk Pulmonary Embolism

Dr. Parth Rali, MD, of Temple University Hospital explained the challenges of managing patients with intermediate-risk pulmonary embolism (PE) and how risk stratification tools can help to address ...
Medscape

Mortality Still Significant in High-Risk PE Despite Advances

1 in 5 patients with high-risk pulmonary embolism (PE) and more than 2 in 5 with catastrophic PE with hemodynamic collapse die in the hospital, a large contemporary analysis showed. Researchers ...
TCTMD

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

Despite frequent use of advanced therapies like systemic thrombolysis and extracorporeal membrane oxygenation (ECMO), high-risk pulmonary embolism (PE) continues to be associated with very high ...
Medscape

Controversy Surrounds Optimal Treatment for High-Risk Pulmonary Embolism

VIENNA — The optimal course of treatment when managing acute, high-risk pulmonary embolism (PE) remains a contentious topic among respiratory specialists. Systemic thrombolysis, specifically using ...
TCTMD

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Photo Credit: Adapted from Ruzsa, Z. Catheter directed thrombolysis and mechanical thrombectomy pulmonary embolism. Presented at: TCT 2014. Washington, DC. Conventional catheter-directed thrombolysis ...
Healthline

Medications for Pulmonary Embolism

Medications for pulmonary embolism may decrease the size of blood clots, help dissolve them, or reduce the risk of recurrence. All of these medications carry the risk of bleeding. A pulmonary embolism ...